About Contact Us Careers

Ultrasound Contrast Agents Market Trends

Request Free Sample Copy

Report ID: 3241
Published Date: Aug 30, 2024
Report Format: PDF, PPT

Buy Now

Ultrasound Contrast Agents Market Trends

Growth Drivers

Growing Use of Ultrasound Diagnosis
Increasing Prevalence of Chronic Diseases Globally

Challenges

Allergic Reactions and Side Effects
Short Term Effect of the Agents

Ultrasound Contrast Agents Market: Key Insights

Base Year	2023
Forecast Year	2024–2036
CAGR	19.8%
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Ultrasound Contrast Agents Market Size & Share | Growth Analysis 2036

Author Credits: Radhika Pawar

Report ID: 3241
Published Date: Aug 30, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Ultrasound Contrast Agents Market size is set to expand at over 19.8% CAGR during the forecast period i.e., between 2024-2036.

Rising prevalence of chronic disorders and increasing implementation of ultrasound diagnosis will fuel the market growth.

Asia Pacific is predicted to dominate majority revenue share by 2036, owing to increasing necessity for advanced diagnosis methods to detect various disease indications such as neurological disorders, cancer, cardiovascular diseases, and others.

The major players in the market include Bristol-Myers Squibb, GE Healthcare, Lantheus Holdings, Inc., Bracco Diagnostic Inc., Siemens Healthcare GmbH, and others.

Inquiry Before Buying Request Free Sample